GLP-1 agonist therapy for advanced heart failure with reduced ejection fraction: design and rationale for the functional impact of GLP-1 for heart failure treatment study
Using research grade peptides carries severe risks, including bacterial contamination and toxic impurities
Beyond gastrointestinal effects, clinicians should monitor for several less common but clinically significant adverse events
Understanding your genetic and biomarker profile before starting GLP-1 allows your provider to anticipate GI tolerability, design a titration schedule that matches your adaptation capacity, and select a formulation (PlexusDx offers compounded semaglutide, tirzepatide, and micro-dose protocols) aligned with your risk profile
Whats happening: Your provider reassesses IGF-1 and overall response
Reputable telehealth platforms (like the ones weve covered above) work with licensed, FDA-registered compounding pharmacies that follow strict preparation standards